Study of the Wound-Healing Activity of a New Drug Derived from Cobalt Polyacrylate
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26030899 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna P Vasilyeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vavilov Institute of General Genetics RAS, Gubkin Str. 3, GSP-1, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Wound Healing, Acrylic Resins, Cobalt. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation. Additional Agreement to State Assignment, Additional Agreement to State Assignment.
Abstract (Originalsprache)
Previously we suggested a new pharmaceutical derived from coordination complex of Co3+ with polyacrylic acid (PAA) exhibiting hemostatic and microbicidal activity, namely Hestatin. Differences in the physiological activity of Hestatin synthesized from PAA 10 kDa (Hestatin 10) and 200 kDa (Hestatin 200) were shown. We tested the acute toxicity of Hestatin and its effect on the healing rate of sterile wounds in rats. Free 10 kDa PAA, emulsion wax, emulsion wax carrying resveratrol, and dexpanthenol were tested for comparison. Hestatin 10 exhibited no acute toxicity when administered intragastrically at dosages of 5 g per kg. Hestatin 10 surpassed all tested drugs in its wound healing ability. Histological analysis of skin sections of rats in the area of healing defects showed an increased rate of synthesis of reticular fibers compared to the placebo. In the early stages of wound healing (inflammatory phase), Hestatin 10 stimulated taxis of mast cells (MCs) to the wound bottom but not to the wound perimeter. At the final stage of wound healing (remodeling phase), Hestatin 10 promoted MC evacuation from the skin defect area. This effect is the opposite of the well-known wound-healing agents (dexpanthenol and resveratrol), which enhance MC infiltration into the defect area in the remodeling phase.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vavilov Institute of General Genetics RAS, Gubkin Str. 3, GSP-1, 119991 Moscow, Russia.
- Innotech-21 LLC, Lyubertsy, Prospect Oktyabrsky, 145, VI, 140000 Moscow, Russia.
- Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, Leninsky Prospect, 47, 119334 Moscow, Russia.
- Research Institute of Experimental Biology and Medicine, Department of Histology, Burdenko Voronezh State Medical University, Studencheskaya Str. 10, 394036 Voronezh, Russia.
ORCID-Profile: Anna P Vasilyeva, Oleg A Rakitin, Victoria V Shishkina, Tatyana V Samoylenko, Alexei B Shevelev
Förderung
- Ministry of Science and Higher Education of the Russian Federation. Additional Agreement to State Assignment
- Additional Agreement to State Assignment
Zitieren
APA
Vasilyeva, A. P., Svinarev, A. V., Ogurtsov, V. A., Khodot, E. N., Rakitin, O. A., Trubnikova, E. V., Shcherbakova, E. S., Smirnova, M. S., Shishkina, V. V., Samoylenko, T. V., & Shevelev, A. B. (2025). Study of the Wound-Healing Activity of a New Drug Derived from Cobalt Polyacrylate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26030899
Vancouver
Vasilyeva AP, Svinarev AV, Ogurtsov VA, Khodot EN, Rakitin OA, Trubnikova EV, et al. Study of the Wound-Healing Activity of a New Drug Derived from Cobalt Polyacrylate. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26030899
BibTeX
@article{Vasilyeva2025,
author = {Vasilyeva, Anna P and Svinarev, Andrey V and Ogurtsov, Vladimir A and Khodot, Evgeny N and Rakitin, Oleg A and Trubnikova, Elena V and Shcherbakova, Elena S and Smirnova, Maria S and Shishkina, Victoria V and Samoylenko, Tatyana V and Shevelev, Alexei B},
title = {Study of the Wound-Healing Activity of a New Drug Derived from Cobalt Polyacrylate},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26030899}
}
EUVIMED